Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Operations

v3.10.0.1
Condensed Consolidated Statements Of Operations - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Condensed Consolidated Statements Of Operations [Abstract]        
Net revenues $ 5,501,730 $ 4,314,068 $ 10,661,215 $ 9,963,186
Cost of sales 2,424,235 2,019,154 5,069,804 4,738,333
Gross profit 3,077,495 2,294,914 5,591,411 5,224,853
Operating expenses:        
Research and development 3,787,562 302,071 7,822,724 1,677,029
Selling, general and administrative 4,027,453 3,184,484 10,875,201 8,259,003
Loss on settlement of accounts receivable 227,208   3,991,346  
Business acquisition   74,495   1,008,880
Total operating expenses 8,042,223 3,561,050 22,689,271 10,944,912
Operating loss (4,964,728) (1,266,136) (17,097,860) (5,720,059)
Non-operating expenses:        
Interest expense (1,380,122) (1,730,717)
Other income (expense), net 64 (13,323) (15,516) (35,630)
Change in fair value of derivative liabilities (378,000) (399,000)
Foreign currency transaction loss (1,591) (20,143) (118,124) (40,838)
Total non-operating expenses (1,759,649) (33,466) (2,263,357) (76,468)
Loss before income taxes (6,724,377) (1,299,602) (19,361,217) (5,796,527)
Income tax expense (benefit) 1,206,131 (509,713) (3,342,339) (1,863,815)
Net loss $ (7,930,508) $ (789,889) $ (16,018,878) $ (3,932,712)
Net loss per basic and diluted common share outstanding $ (0.15) $ (0.03) $ (0.30) $ (0.13)
Basic and diluted weighted average common shares outstanding 53,789,409 30,991,247 53,432,404 30,983,271